NYSE:TAK

Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

$16.21

+0.09 (+0.56%)

(As of 06/9/2023 ET)

Compare

Today's Range: $16.16
▼
$16.28
50-Day Range: $15.84
▼
$17.11
52-Week Range: $12.28
▼
$17.15

Volume: 1.64 million shs
Average Volume: 2.48 million shs
Market Capitalization: $51.30 billion

P/E Ratio: 21.05
Dividend Yield: 1.67%
Price Target: $24.67

Earnings Per Share Revenue

TAK Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

TAK Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Takeda Pharmaceutical Analyst Forecasts

Current Year EPS Consensus Estimate: $0.33 EPS

TAK Earnings Date and Information

Takeda Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 27th, 2023 based off prior year's report dates.

Takeda Pharmaceutical Earnings History by Quarter

Export to Excel

Date	Quarter	Reported EPS	Beat/Miss	GAAP EPS	Actual Revenue
7/27/2023 (Estimated)
2/2/2023	Q3 2023	$0.46	+$0.46	$0.63	$8.40 billion
10/27/2022	Q2 2023	$0.52	+$0.52	$0.90	$7.26 billion
7/28/2022	Q1 2023	$0.56	+$0.56	$0.86	$7.51 billion
5/11/2022	Q4 2022	$0.38	+$0.38	$0.79	$7.19 billion
2/3/2022	Q3 2022	$0.54	+$0.54	$0.91	$8.21 billion
10/28/2021	Q2 2022	$0.45	+$0.45	$0.77	$7.67 billion

7/30/2021	Q1 2022	$0.51	+$0.51	$0.44	$8.68 billion
5/11/2021	Q4 2021	$0.41	+$0.41	$0.23	$7.27 billion
2/4/2021	Q3 2021	$0.56	+$0.56	$0.84	$8.01 billion
10/29/2020	Q2 2021	$0.47	+$0.47	$0.93	$7.43 billion
7/31/2020	Q1 2021	$0.57	+$0.57	$0.89	$7.46 billion
5/13/2020	Q4 2020	$0.13	+$0.13	$0.25	$7.09 billion
2/4/2020	Q3 2020	$0.53	+$0.53	$1.03	$7.90 billion
10/31/2019	Q2 2020	$0.59	+$0.59	$1.02	$7.56 billion
7/31/2019	Q1 2020	$0.56	+$0.56	$1.18	$7.73 billion
5/14/2019	Q4 2019	$0.13	+$0.13	$0.13	$3.51 billion
2/1/2019	Q3 2019	$0.75	+$0.75	$1.29	$4.43 billion
10/31/2018	Q2 2019	$0.61	+$0.61	$0.94	$3.86 billion
7/31/2018	Q1 2019	$0.69	+$0.69	$0.92	$4.12 billion
5/14/2018	Q4 2018	($0.32)	($0.32)	($0.32)	$3.70 billion
2/1/2018	Q3 2018	$0.39	+$0.39	$0.39	$4.33 billion
11/1/2017	Q2 2018	$0.46	+$0.46	$0.76	$3.91 billion
7/28/2017	Q1 2018	$0.47	+$0.47	$0.10	$4.04 billion
5/10/2017	Q4 2017	($0.29)	($0.29)	($0.29)	$3.66 billion
2/1/2017	Q3 2017	$0.24	+$0.24	$0.24	$4.27 billion
10/28/2016	Q2 2017	$0.16	+$0.16	$0.16	$4.07 billion
7/29/2016	Q1 2017	$0.59	+$0.59	$0.59	$4.02 billion
5/10/2016	Q4 2016	$0.07	+$0.07	$0.33	$3.59 billion
2/3/2016	Q3 2016	$0.31	+$0.31	$0.31	$4.06 billion
10/30/2015	Q2 2016	$0.15	+$0.15	$0.15	$3.75 billion
7/30/2015	Q1 2016	$0.13	+$0.13	$0.13	$3.66 billion
5/15/2015	Q4 2015	$0.05	+$0.05	$1.30	$3.67 billion
2/5/2015	Q3 2015	$0.10	+$0.10	$0.10	$4.15 billion
10/30/2014	Q2 2015	$0.16	+$0.16	$0.16	$4.08 billion
8/1/2014	Q1 2015	$0.21	+$0.21	$0.21	$4.02 billion
5/8/2014	Q4 2014	($0.03)	($0.03)	($0.03)	$3.98 billion
2/5/2014	Q3 2014	$0.29	+$0.29	$0.29	$4.53 billion
10/31/2013	Q2 2014	$0.14	+$0.14	$0.05	$4.22 billion
7/31/2013	Q1 2014	$0.20	+$0.20	$0.21	$4.17 billion
5/9/2013	Q4 2013	$0.54	+$0.54	$0.79	$3.72 billion

Takeda Pharmaceutical Earnings - Frequently Asked Questions

When is Takeda Pharmaceutical's earnings date?: Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 27th, 2023 based off last year's report dates. Learn more on TAK's earnings history.

How much revenue does Takeda Pharmaceutical generate each year?: Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $4.03 trillion.
How much profit does Takeda Pharmaceutical generate each year?: Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $2.35 billion. TAK has generated $0.77 earnings per share over the last four quarters.
What is Takeda Pharmaceutical's price-to-earnings ratio?: Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 21.05 and a forward price-to-earnings ratio of 49.12. The price/earnings-to-growth ratio is 9.05.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NYSE:TAK) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts

TAK Earnings Estimates and Actuals by Quarter

TAK Estimated and Actual Revenue by Quarter

Takeda Pharmaceutical Analyst Forecasts

TAK Earnings Date and Information

Takeda Pharmaceutical Earnings History by Quarter

Takeda Pharmaceutical Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info